Study Shows Accuracy of Optical Biopsy Over Traditional Endoscopic Biopsy

Mauna Kea Technologies, a global optical biopsy company, recently conducted a study that showed its Cellvizio optical biopsy device had greater accuracy in detecting stomach cancer than traditional endoscopic biopsy.

Advertisement

Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

The study conducted in Korea found that optical biopsy had a 91.7 percent accuracy rate in detecting stomach cancer, while traditional endoscopic biopsies had an 85.2 percent accuracy rate.

More Articles on Gastroenterology:

Memorial Hermann Northeast Hospital Names Dr. Howard Hamat Chief of Staff
CMS Requires Gastroenterologist to Document Quality of Care
Gastrointestinal Device Market Estimated at $33B by 2023

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.